echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Ann Rheum Dis: Similar to Kawasaki disease, multisystem inflammatory syndrome in children associated with SARS-CoV-2 (Kawa-COVID-19)

    Ann Rheum Dis: Similar to Kawasaki disease, multisystem inflammatory syndrome in children associated with SARS-CoV-2 (Kawa-COVID-19)

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Current data show that the prevalence of COVID-19 in children is low and the incidence is mildBut the number of children visiting hospitals in the greater Paris region in the past few weeks, similar to Kawasaki disease (KD), has increased, prompting the French national health authority to issue an alarmMulticenter editing (Kawa-COVID-19) was made to KD patients in the Paris region associated with the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since April 2020A "classic" KD historical queue is compared16 patients were included (sex ratio of 1, median age 10 years, IQR (4.7-12.5).)11 patients were tested for SARS-CoV-2 (69%), while another 5 patients reported recent exposure to quantitative PCR-positive individuals (31%)Heart conditioning included myocarditis in 44% of patients (n-7)The predictors of progress towards a serious disease (i.e., need ingestion in intensive care, n-7) are over 5 years of age and ferriteOnly 5 patients (31%) had successful treatment of immunoglobulin (IVIg), while 10 patients (62%) required second-line treatmentThe difference between the Kawa-COVID-19 queue and the "classic" KD control group is that the onset age is older (10 years vs 2 years old (p 0.0001) and the platelet count is low (188 vs 383G/L (p 0.0)" high incidence of myocarditis (7/16 vs 3/220 (p-0.001)) and first IVIg treatment resistance (10/16 vs 45/220 (p-0.004)Kawa-COVID-19 may represent a new systemic inflammatory syndrome that is time-related to SARS-CoV-2 infectionFurther prospective international studies are necessary to confirm these findings and better understand the pathophysiology of Kawa-COVID-19
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.